Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Iterum Therapeutics plc ITRM

Healthcare
Iterum Therapeutics plc is a clinical-stage pharmaceutical company. The Company develops differentiated anti-infectives aimed at combatting the global crisis of multi-drug resistant pathogens to significantly improve the lives of people affected by serious and life-threatening diseases around the world. It is advancing its first compound, sulopenem, a novel penem anti-infective compound, in... see more

Bullboard (NDAQ:ITRM)

View:
Post by MikeTesteron Aug 03, 2024 2:09am

Iterum Therapeutics plc: Resubmitted NDA for Oral Sulopenem

https://beyondspx.com/2024/08/02/iterum-therapeutics-plc-resubmitted-nda-for-oral-sulopenem-positions-company-for-potential-approval-in-q4-2024/
31
Post by whytestockson Jun 05, 2024 10:00pm

Iterum Therapeutics to Present Data at ASM Microbe 2024

BREAKING NEWS: $ITRM Iterum Therapeutics to Present Data at ASM Microbe 2024DUBLIN and CHICAGO, June 05, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage ...more  
37
Post by Iseneschalon Dec 15, 2022 1:58pm

ITRM .... if and thats a big if ; )

This can bust thru $1.25 with some vols....I will entertain the idea to take a position
67
Post by Iseneschalon Dec 15, 2022 12:30pm

ITRM ...... What a deal ; )

LoL.....1 big P & D Now at L.O.D $1.17 What now ?
70
Post by wallpaper2on Jun 27, 2021 10:18am

Telling after close purchase on Iterum.

Someone purchased 25000 shares at S2.23 at the close. Six million shares crossed earlier. Something very good happening? Three weeks of trading before FDA approval and multiple move in share price ...more  
176
Post by wallpaper2on Jun 22, 2021 10:46am

We're very close folks.

FDA decision July 24th and a lot of buying has taken place this month! FDA were satisfied with everything after their last get together. Rubber meets the road soon.
124
Comment by wallpaper2on Jun 14, 2021 12:42pm

RE:ITRM on verge of breakout on expected FDA approval ??

It wants to run but they are smart and backfilling first.
106
Discussion
Post by wallpaper2on Jun 12, 2021 1:29pm

ITRM on verge of breakout on expected FDA approval ??

You tell me.... volume and sp both moving higher which is very bullish. Are people in the know cheating and getting in early on anticipation. Was the recent meeting with the FDA a big positive. WC ...more  
248
Discussion
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities